• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Mereo BioPharma Group plc - American Depositary Shares (NQ:MREO)

    0.4141 +0.0041 (+1.00%)
    Streaming Delayed Price Updated: 4:00 PM EST, Mar 4, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,635,146
    Open 0.3933
    Bid (Size) 0.4051 (21,700)
    Ask (Size) 0.4200 (4,500)
    Prev. Close 0.4100
    Today's Range 0.3901 - 0.4199
    52wk Range 0.2000 - 3.050
    Shares Outstanding 584,908,239
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    UPCOMING DEADLINE: Mereo BioPharma (MREO) Securities Fraud Class Action – April 6, 2026 Lead Plaintiff Deadline - Faruqi & Faruqi LLP
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO
    From Pomerantz LLP
    Via GlobeNewswire

    Performance

    YTD
    -18.9%
    -18.9%
    1 Month
    -4.3%
    -4.3%
    3 Month
    -78.9%
    -78.9%
    6 Month
    -76.1%
    -76.1%
    1 Year
    -83.4%
    -83.4%

    More News

    Read More
    News headline image
    MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    MREO CLASS ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on March 6, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    MREO INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Mereo BioPharma (MREO) Investors of Securities Class Action Deadline on April 6, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Stockholders Who Lost Money Investing in Mereo BioPharma Group plc Should Contact Robbins LLP for Information About Recovering Their Losses from MREO
    From Robbins LLP
    Via GlobeNewswire
    News headline image
    CLASS ACTION ALERTS: Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ultragenyx and Mereo BioPharma and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Mereo BioPharma Group plc of Class Action Lawsuit and Upcoming Deadlines – MREO
    From Pomerantz LLP
    Via GlobeNewswire
    News headline image
    MREO SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Reminds Mereo (MREO) Investors of Securities Class Action Deadline on April 6, 2026
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    News headline image
    MREO Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Mereo BioPharma Group plc Class Action
    From Robbins LLP
    Via GlobeNewswire
    News headline image
    ATTENTION NASDAQ: MREO INVESTORS: Contact Berger Montague About a Mereo BioPharma Group PLC Class Action Lawsuit
    From Berger Montague
    Via GlobeNewswire
    News headline image
    ROSEN, LEADING INVESTOR COUNSEL, Encourages Mereo BioPharma Group plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – MREO
    From The Rosen Law Firm PA
    Via GlobeNewswire
    News headline image
    Mereo BioPharma Group plc Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – MREO
    From DJS Law Group
    Via Business Wire
    News headline image
    MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    News headline image
    MEREO LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Mereo BioPharma Group plc and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Mereo BioPharma
    From Faruqi & Faruqi LLP
    Via GlobeNewswire
    News headline image
    Rosen Law Firm Urges Mereo BioPharma Group plc (NASDAQ: MREO) Stockholders to Contact the Firm for Information About Their Rights
    From The Rosen Law Firm, P.A.
    Via Business Wire
    News headline image
    Investor Notice: Shareholder Rights Law Firm Robbins LLP Informs Investors of the Mereo BioPharma Group plc Securities Class Action Lawsuit
    From Robbins LLP
    Via Business Wire

    Frequently Asked Questions

    Is Mereo BioPharma Group plc - American Depositary Shares publicly traded?
    Yes, Mereo BioPharma Group plc - American Depositary Shares is publicly traded.
    What exchange does Mereo BioPharma Group plc - American Depositary Shares trade on?
    Mereo BioPharma Group plc - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Mereo BioPharma Group plc - American Depositary Shares?
    The ticker symbol for Mereo BioPharma Group plc - American Depositary Shares is MREO on the Nasdaq Stock Market
    What is the current price of Mereo BioPharma Group plc - American Depositary Shares?
    The current price of Mereo BioPharma Group plc - American Depositary Shares is 0.4141
    When was Mereo BioPharma Group plc - American Depositary Shares last traded?
    The last trade of Mereo BioPharma Group plc - American Depositary Shares was at 03/04/26 04:00 PM ET
    What is the market capitalization of Mereo BioPharma Group plc - American Depositary Shares?
    The market capitalization of Mereo BioPharma Group plc - American Depositary Shares is 242.21M
    How many shares of Mereo BioPharma Group plc - American Depositary Shares are outstanding?
    Mereo BioPharma Group plc - American Depositary Shares has 242M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.